In situ splitting after selective partial portal vein ligation or simultaneous hepatic artery ligation promotes liver regeneration

被引:0
作者
Li-Bin Yao
Chong-Hui Li
Xiao-Juan Wu
Xue-Dong Wang
Xin-Lan Ge
Ai-Qun Zhang
Xiao-Cheng Zhu
Yong Shao
Jia-Hong Dong
机构
[1] Beijing Tsinghua Changguang Hospital,The Center for Hepatopancreatobiliary Diseases
[2] Tsinghua University Medical Center,Department of General Surgery
[3] the Affiliated Hospital of Xuzhou Medical University,Institute of Hepatobiliary Surgery
[4] Chinese PLA General Hospital,Department of Nephrology
[5] Chinese PLA Medical School,undefined
[6] Huai’an Hospital Affiliated to Xuzhou Medical University and Huai’an Second Hospital. Qingpu District,undefined
来源
Scientific Reports | / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This study seeks to compare the impact of selective partial portal vein ligation (PPVL) or the combination of simultaneous hepatic artery ligation (PPVAL) with in situ splitting (ISS) on liver regeneration and injury. Rats were randomized into three groups; namely: selective PVL, PPVL + ISS and PPVAL + ISS. The changes in hepatic hemodynamics, liver regeneration and hepatocytic injury were examined. Blood flow to the left portal branch and the microcirculation of the left median lobe after PPVL or PPVAL was significantly reduced. Liver regeneration of PPVAL + ISS group was more pronounced than that in the PPVL + ISS and PVL groups at 48 and 72 hours as well as 7 d postoperatively. The serum biochemical markers and histopathological examination demonstrated reduced levels of liver injury in the PPVL + ISS group. Injury to hepatocytes was more pronounced with PPVAL + ISS than PVL. HGF, TNF-α and IL-6 expression in the regenerated lobes in both PPVAL + ISS and PPVL + ISS groups increased significantly when compared to the PVL group. We demonstrated that both PPVL + ISS and PPVAL + ISS were effective and feasible means of inducing remnant liver hypertrophy and could serve as a rapid clinical application for qualified patients.
引用
收藏
相关论文
共 48 条
[1]  
Fonseca AL(2014)Hepatocellular carcinoma: a comprehensive overview of surgical therapy J. Surg. Oncol. 110 712-719
[2]  
Cha CH(2014)Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease Eur. J. Cancer. 50 1747-1757
[3]  
Hwang M(1990)Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report Surgery 107 521-527
[4]  
Makuuchi M(2007)Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome Br. J. Surg. 94 1386-1394
[5]  
Ribero D(2008)Preoperative portal vein embolization for major liver resection: a meta-analysis Ann. Surg. 247 49-57
[6]  
Abulkhir A(2009)Present status and future perspectives of preoperative portal vein embolization The Am. J. Surg. 197 686-690
[7]  
Liu H(2013)Portal vein embolization before liver resection: a systematic review Cardiovasc. Intervent. Radiol. 36 25-34
[8]  
Zhu S(2013)Tumour progression and liver regeneration–insights from animal models Nat. Rev. Gastroenterol. Hepatol. 10 452-462
[9]  
van Lienden KP(1985)Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response Am. J. Physiol. 249 G549-556
[10]  
Lim C(1985)Adenosine as putative regulator of hepatic arterial flow (the buffer response) Am. J. Physiol 248 H331-338